ONCOLYTICS BIOTECH RSS Feed | Nachrichten - www.finanzen.net

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance

Fri, 12 Dec 2025 16:47:00 +0100

Issued on behalf of Oncolytics Biotech Inc.

VANCOUVER, BC, Dec. ...

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance

Fri, 12 Dec 2025 16:47:00 +0100

Issued on behalf of Oncolytics Biotech Inc.

VANCOUVER, BC, Dec. ...

Oncolytics Biotech hat die Zahlen zum jüngsten Quartal vorgelegt

Sat, 15 Nov 2025 06:35:06 +0100

Oncolytics Biotech hat am 12.11.2025 die Geschäftsergebnisse zum jüngsten Jahresviertel vorgestellt.In Sachen EPS wurde ein Verlust von 0,10 USD je Aktie ausgewiesen. Im vergangenen Jahr hatte Oncolytics ...

Oncolytics Biotech® Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care

Tue, 28 Oct 2025 12:30:00 +0100

Pelareorep plus atezolizumab achieves 30% ORR in second-line or later (≥2L) squamous cell anal carcinoma (SCAC) relative to 13.8% for the FDA-approved 2L treatment

The ...

Oncolytics Biotech® Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care

Tue, 28 Oct 2025 12:30:00 +0100

Pelareorep plus atezolizumab achieves 30% ORR in second-line or later (≥2L) squamous cell anal carcinoma (SCAC) relative to 13.8% for the FDA-approved 2L treatment
The ...

Oncolytics Biotech® Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada

Mon, 20 Oct 2025 15:00:00 +0200

SAN DIEGO, Oct. 20, 2025 /CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) ("Oncolytics" or the ...

Oncolytics Biotech® Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada

Mon, 20 Oct 2025 15:00:00 +0200

SAN DIEGO, Oct. 20, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) ("Oncolytics" ...